This study has flaws. Namely, the ivermectin was only administered with patients after 7 days of symptomatic COVID infection. Meanwhile Paxlovid, the patented

This study has flaws. Namely, the ivermectin was only administered with patients after 7 days of symptomatic COVID infection. Meanwhile Paxlovid, the patented ACE2 inhibitor is received as a proven treatment when administered early in infection. 7 days after symptoms appear is not early. The game is rigged my friend